Results 101 to 110 of about 142,530 (222)

Trade Liberalization and Labor Market Monopsony Power: Evidence From China

Review of International Economics, Volume 34, Issue 3, Page 632-657, August 2026.
ABSTRACT We study the effect of trade liberalization on firms' monopsony power in the labor market. We estimate firm‐specific markdowns from production data in the manufacturing industry and document the trends in China between 1998 and 2007. Taking China's entry to the WTO as a policy shock, we use a difference‐in‐differences (DiD) approach combined ...
Pengzhan Qian, Dan Xie
wiley   +1 more source

Formal Approach to Safety‐Driven Dynamic Procedure Modeling

Systems Engineering, Volume 29, Issue 4, July 2026.
ABSTRACT Ensuring the safety of unmanned aerial systems (UAS) is a growing concern as the number of UAS grows increasingly fast. Regulatory bodies are in the process of tackling this problem by issuing standards and recommendations to be met by UAS designers.
Jean‐Charles Chaudemar, Kevin Delmas, Charles Mathou, Pierre de Saqui‐Sannes   +3 more
wiley   +1 more source

Liquid jet capabilities for ultrafast chemistry at the SwissFEL Alvra instrument

Journal of Synchrotron Radiation, Volume 33, Issue 4, Page 1219-1235, July 2026.
The technical aspects of the Alvra endstation are outlined and its scientific capabilities are demonstrated with commissioning results obtained during the early years of SwissFEL's operation.The Alvra experimental station at the Swiss X‐ray free‐electron laser, SwissFEL, investigates ultrafast dynamics in chemical and biological systems using X‐ray ...
Claudio Cirelli, Emma Victoria Beale, Florian Dworkowski, Victoria Kabanova, Sven Augustin, Gregor Knopp, Chris Milne, Christoph Bostedt, Philip J. M. Johnson, Camila Bacellar   +9 more
wiley   +1 more source

One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 2, Page 235-242, July 2026.
In a real‐world cohort of patients with highly refractory perianal Crohn's disease, upadacitinib induced clinical remission at 12 months in 26% of patients with fistulizing disease and 25% of those with isolated anal ulcerations. ABSTRACT Introduction Upadacitinib (UPA) is effective for treating luminal Crohn's disease (CD), but data on perianal CD ...
Nicolas Richard, Philippe Seksik, Romain Altwegg, Maria Nachury, David Laharie, Stéphane Nancey, Benoît Coffin, Anne‐Laure Pelletier, Mathieu Uzzan, Aurélien Amiot, Morgane Amil, Lucine Vuitton, Mathurin Fumery, Anne Bozon   +13 more
wiley   +1 more source

The Valanginian - Lower Hauterivian of SE France

, 2015
A l’occasion de l’inauguration de l’Espace Naturel Sensible du Serre de l’Âne (le 5/12/14 à La Charce), une présentation de ce site a été faite (S. Reboulet) lors de la dernière réunion du GFC (2-3/12/14) et il a été proposé de faire une excursion sur la coupe de La Charce (GSSP Hauterivien).
openaire   +1 more source

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6022-6033, July 2026.
ABSTRACT Aims The American Diabetes Association recommends achieving treatment goals (glycated haemoglobin ≤ 53 mmol/mol [7.0%], blood pressure < 130/80 mmHg, low‐density lipoprotein cholesterol < 1.81 mmol/L and use of sodium–glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists), to reduce cardiovascular and kidney ...
João Sérgio Neves, Ana Rita Leite, Francisco Vasques‐Nóvoa, Bertram Pitt, Gerasimos Filippatos, Luis M. Ruilope, Peter Rossing, Stefan D. Anker, Gianluigi Savarese, Charlie A. B. Scott, Andrea Lage, Meike D. Brinker, João Pedro Ferreira   +12 more
wiley   +1 more source

Worldwide Invasions of Centrarchidae: The Dark Side of the Sunfish Family

Fish and Fisheries, Volume 27, Issue 4, Page 781-812, July 2026.
ABSTRACT Freshwater fish invasions are major drivers of global ecological change, disrupting native biodiversity and ecosystem functions. However, many invasive fish hold significant socioeconomic value, resulting in conflict over their management. Centrarchidae, which are globally distributed and are important for sportfishing and aquaculture, are now
Neil Angelo Abreo, Jonathan Tibo, António Barbosa Nogueira, Athanasios Nikolaou, Cüneyt Kaya, Ali Serhan Tarkan, Irmak Kurtul, Stelios Katsanevakis, Ronaldo Sousa, Teun Everts, Emili García‐Berthou, John S. Hargrove, Ana Clara Sampaio Franco, Jelger Erik Herder, Julian D. Olden, Darragh J. Woodford, Antonín Kouba, J. Rob Britton, Ismael Soto, Phillip J. Haubrock   +19 more
wiley   +1 more source

A Prospective Clinical Study to Confirm the Safety and Performance of a Canister‐Based Single‐Use Negative Pressure Wound Therapy System in Low‐to‐Moderately Exuding Chronic Wounds

International Wound Journal, Volume 23, Issue 7, July 2026.
ABSTRACT This clinical investigation was undertaken to confirm the safety and performance of a canister‐based single‐use negative pressure wound therapy system when used as intended in the management of low‐to‐moderately exuding chronic wounds, including diabetes‐related foot ulcers (n = 34), venous leg ulcers (n = 34), and pressure ulcers (n = 36) for
Berthold Amann, Michel Danneels, Joao Castro, Diletta Loschi, Mary‐Paula Colgan, Gomez Carlos Filipe, Vieira Nuna, Kerstin Kusch, Monira Nou Howaldt, Lorenzo Gibello, Fabio Verzini, Markus Stücker, Paulo Alves, Hilde Beele   +13 more
wiley   +1 more source

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1195-1207, July 2026.
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat, Shawn G. Kwatra, Adam Reich, Serge Boulinguez, Athanasios Tsianakas, Maxwell Sauder, Sebastien Barbarot, Jacek C. Szepietowski, Curdin Conrad, Andrew E. Pink, Elke Weisshaar, Laurent Misery, Martin Metz, Vivian T. Laquer, Raja K. Sivamani, Gil Yosipovitch, Diamant Thaçi, Lone Skov, Xiaoxiao Chen, Aliene Noda, Zarif K. Jabbar‐Lopez, Christophe Piketty, Sonja Ständer   +22 more
wiley   +1 more source

Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1208-1217, July 2026.
The results of this French Early Access Program were consistent with those reported in dupilumab randomized clinical trials in children aged 6 months–5 years with moderate‐to‐severe AD. This research offers insights into the practical use of dupilumab in routine clinical practice.
Audrey Lasek, Nathalia Bellon, Stéphanie Mallet, Hélène Aubert, Carine Vera, Lamia Achour, Claire Thénié, Randy Prescilla, Claire Abasq‐Thomas, Sébastien Barbarot   +9 more
wiley   +1 more source